XTL Biopharmaceuticals Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 0 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
XTL Biopharmaceuticals Ltd. Earnings Date And Information
XTL Biopharmaceuticals Ltd. last posted its earnings results on Tuesday, December 1st, 2015. The company reported $-0.2 earnings per share for the quarter, missing analysts' consensus estimates of $-0.05 by $0.15. The company had revenue of 0 for the quarter and had revenue of 0 for the year. XTL Biopharmaceuticals Ltd. has generated $0 earnings per share over the last year ($-0.0003 diluted earnings per share) and currently has a price-to-earnings ratio of -36.9. XTL Biopharmaceuticals Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, September 26th, 2024 based on prior year's report dates.
XTL Biopharmaceuticals Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/29/2024 | Q1 2024 | $0.09 | $0 | $0 | ||
| 04/30/2024 | Q4 2023 | -$0.05 | $0 | $0 | ||
| 09/29/2023 | Q3 2023 | -$0.04 | $0 | $0 | ||
| 06/30/2023 | Q2 2023 | -$0.07 | $0 | |||
| 03/31/2023 | Q1 2023 | -$0.29 | $0 | |||
| 03/22/2023 | Q4 2022 | -$0.24 | $-459,000 | |||
| 09/29/2022 | Q3 2022 | -$0.26 | $0 | |||
| 08/24/2022 | Q2 2022 | -$0.07 | $0 | |||
| 08/24/2022 | Q1 2022 | $0.23 | $0 | |||
| 03/30/2022 | Q4 2021 | $0.40 | $1.47 M | |||
| 09/29/2021 | Q3 2021 | -$0.09 | $0 | |||
| 08/24/2021 | Q2 2021 | -$0.16 | $0 | |||
| 08/24/2021 | Q1 2021 | $0.10 | $0 | |||
| 03/15/2021 | Q4 2020 | -$0.20 | $28,000 | |||
| 09/29/2020 | Q3 2020 | -$0.11 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.18 | $0 | |||
| 03/31/2020 | Q1 2020 | $0.01 | $0 | |||
| 03/12/2020 | Q4 2019 | -$0.22 | $69,000 | |||
| 09/29/2019 | Q3 2019 | -$0.24 | $0 | |||
| 06/29/2019 | Q2 2019 | -$0.56 | $0 |
XTL Biopharmaceuticals Ltd. Earnings: Frequently Asked Questions
-
When is XTL Biopharmaceuticals Ltd.'s earnings date?
XTL Biopharmaceuticals Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, September 26th, 2024 based off last year's report dates.
-
How can I listen to XTL Biopharmaceuticals Ltd.'s earnings conference call?
The conference call for XTL Biopharmaceuticals Ltd.'s latest earnings report can be listened to online.
-
How can I read XTL Biopharmaceuticals Ltd.'s conference call transcript?
The conference call transcript for XTL Biopharmaceuticals Ltd.'s latest earnings report can be read online.
-
How much profit does XTL Biopharmaceuticals Ltd. generate each year?
XTL Biopharmaceuticals Ltd. (:XTLB) has a recorded net income of $0. XTL Biopharmaceuticals Ltd. has generated $-0.0003 earnings per share over the last four quarters.
-
What is XTL Biopharmaceuticals Ltd.'s price-to-earnings ratio?
XTL Biopharmaceuticals Ltd. (:XTLB) has a price-to-earnings ratio of -36.9 and price/earnings-to-growth ratio is -0.37.
